How to buy Bioanalytical Systems stock

Bioanalytical Systems, Inc is a diagnostics & research business based in the US. Bioanalytical Systems shares (BASI) are listed on the NASDAQ and all prices are listed in US Dollars. Bioanalytical Systems employs 397 staff and has a trailing 12-month revenue of around 0.00.

Bioanalytical Systems share price

Use our graph to track the performance of BASI stocks over time.

Bioanalytical Systems shares at a glance

• Key figures

Information last updated 2021-04-29.

52-week range	$3.90 - $23.63
50-day moving average	$17.37
200-day moving average	$10.52
Wall St. target price	$23.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.12

Buy Bioanalytical Systems shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Bioanalytical Systems stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Bioanalytical Systems, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Bioanalytical Systems under- or over-valued?

Valuing Bioanalytical Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bioanalytical Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bioanalytical Systems's EBITDA

Bioanalytical Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.4 million.

The EBITDA is a measure of a Bioanalytical Systems's overall financial performance and is widely used to measure a its profitability.

Bioanalytical Systems financials

Revenue TTM	$65.4 million
Gross profit TTM	$18.2 million
Return on assets TTM	-0.84%
Return on equity TTM	-40.67%
Profit margin	-5.54%
Book value	$0.67
Market capitalisation	$183 million

TTM: trailing 12 months

Shorting Bioanalytical Systems shares

There are currently 57,445 Bioanalytical Systems shares held short by investors – that's known as Bioanalytical Systems's "short interest". This figure is 7.4% up from 53,484 last month.

There are a few different ways that this level of interest in shorting Bioanalytical Systems shares can be evaluated.

Bioanalytical Systems's "short interest ratio" (SIR)

Bioanalytical Systems's "short interest ratio" (SIR) is the quantity of Bioanalytical Systems shares currently shorted divided by the average quantity of Bioanalytical Systems shares traded daily (recently around 108386.79245283). Bioanalytical Systems's SIR currently stands at 0.53. In other words for every 100,000 Bioanalytical Systems shares traded daily on the market, roughly 530 shares are currently held short.

However Bioanalytical Systems's short interest can also be evaluated against the total number of Bioanalytical Systems shares, or, against the total number of tradable Bioanalytical Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bioanalytical Systems's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Bioanalytical Systems shares in existence, roughly 10 shares are currently held short) or 0.0067% of the tradable shares (for every 100,000 tradable Bioanalytical Systems shares, roughly 7 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bioanalytical Systems.

Find out more about how you can short Bioanalytical Systems stock.

Bioanalytical Systems share dividends

We're not expecting Bioanalytical Systems to pay a dividend over the next 12 months.

Bioanalytical Systems share price volatility

Over the last 12 months, Bioanalytical Systems's shares have ranged in value from as little as $3.9 up to $23.63. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bioanalytical Systems's is 2.0033. This would suggest that Bioanalytical Systems's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Bioanalytical Systems overview

Bioanalytical Systems, Inc. , doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally.

Frequently asked questions

• What percentage of Bioanalytical Systems is owned by insiders or institutions?

  Currently 34.924% of Bioanalytical Systems shares are held by insiders and 10.668% by institutions.

• How many people work for Bioanalytical Systems?

  Latest data suggests 397 work at Bioanalytical Systems.

• When does the fiscal year end for Bioanalytical Systems?

  Bioanalytical Systems's fiscal year ends in September.

• Where is Bioanalytical Systems based?

  Bioanalytical Systems's address is: 2701 Kent Avenue, West Lafayette, IN, United States, 47906

• What is Bioanalytical Systems's ISIN number?

  Bioanalytical Systems's international securities identification number is: US09058M1036

• What is Bioanalytical Systems's CUSIP number?

  Bioanalytical Systems's Committee on Uniform Securities Identification Procedures number is: 09058M103